Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 18.60
-0.50 (-2.62%)
At close: Feb 11, 2026
Welgene Biotech Market Cap
Welgene Biotech has a market cap or net worth of 433.45 million as of February 13, 2026. Its market cap has decreased by -19.66% in one year.
Market Cap
433.45M
Enterprise Value
350.35M
Revenue
365.75M
Ranking
n/a
PE Ratio
265.74
Stock Price
18.60
Market Cap Chart
Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 433.45M, a decrease of -24.63%. That is a compound annual growth rate of -3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 433.45M | - |
| Dec 31, 2025 | 433.45M | -21.85% |
| Dec 30, 2024 | 554.64M | 6.49% |
| Dec 29, 2023 | 520.85M | 0.68% |
| Dec 30, 2022 | 517.35M | -9.20% |
| Dec 30, 2021 | 569.79M | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| TaiwanJ Pharmaceuticals | 616.94M |
| Vectorite Biomedical | 610.61M |
| Health & Life | 587.85M |
| Pharmigene | 529.88M |